HBI 3808
Alternative Names: HBI-3808Latest Information Update: 17 Jan 2025
Price :
$50 *
At a glance
- Originator HUYA Bioscience International
- Class Small molecules
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Heart injuries
Most Recent Events
- 18 Dec 2024 Preclinical trials in Heart injuries in USA (PO), prior to December 2024 (HUYA Bioscience International pipeline, December 2024)